Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
144M
-
Number of holders
-
4
-
Total 13F shares, excl. options
-
400K
-
Shares change
-
+173K
-
Total reported value, excl. options
-
$2.63M
-
Value change
-
+$1.13M
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$6.55
Significant Holders of MARAVAI LIFESCIENCES HOLDINGS, INC. - Common Stock (MRVI) as of Q4 2023
4 filings reported holding MRVI - MARAVAI LIFESCIENCES HOLDINGS, INC. - Common Stock as of Q4 2023.
MARAVAI LIFESCIENCES HOLDINGS, INC. - Common Stock (MRVI) has 4 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 400K shares
of 144M outstanding shares and own 0.28% of the company stock.
Largest 10 shareholders include GTCR LLC (21.7M shares), 12 West Capital Management LP (11.6M shares), VANGUARD GROUP INC (10M shares), BlackRock Inc. (6.48M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (6.01M shares), MILLENNIUM MANAGEMENT LLC (5.79M shares), MACKENZIE FINANCIAL CORP (5.17M shares), BRAIDWELL LP (5.04M shares), AQR CAPITAL MANAGEMENT LLC (3.5M shares), and Alyeska Investment Group, L.P. (3.2M shares).
This table shows the top 4 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.